Latest DEF 14A proxy statements

Neuphoria Therapeutics Inc. urges stockholders to vote for its director nominees to ensure stability during a critical strategic review process, following a failed Phase 3 clinical trial.

Coinbase Global, Inc. is reincorporating from Delaware to Texas, citing Texas's pro-business and pro-crypto legal environment and potential cost savings.

Institutional Shareholder Services (ISS) has recommended Tiptree stockholders vote FOR the merger of its subsidiary Fortegra with DB Insurance Co., Ltd. in an all-cash deal.

Akero Therapeutics filed a supplement to its definitive proxy statement for the upcoming special meeting, providing additional disclosures regarding its proposed merger with Novo Nordisk and addressing two stockholder lawsuits.

dMY Squared Technology Group, Inc. is seeking shareholder approval to extend its deadline to complete a business combination with Horizon Quantum Computing Pte. Ltd. until June 29, 2026, following its delisting from NYSE American.

The OLB Group, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation.

Churchill Capital Corp IX announced its annual general meeting for December 19, 2025, primarily to ratify the selection of WithumSmith+Brown, PC as its independent auditor for the fiscal year ending December 31, 2025.

Enviri Corporation announced a definitive agreement to sell its Clean Earth business to Veolia for $3 billion and spin off Harsco Environmental and Rail into a new public company, New Enviri.

Nocera, Inc. will hold its 2025 Annual Meeting to vote on key proposals including a reverse stock split, an increase in authorized shares, and the potential issuance of common stock from convertible securities.

Enviri Corporation announces the sale of its Clean Earth business to Veolia Environnement S.A. for $3 billion, significantly reducing debt and creating a new, financially healthier 'New Enviri' focused on Harsco Environmental and Rail.

Movano Inc. calls a special meeting to approve a $1 billion equity facility, a five-fold increase in authorized shares, and expanded stock options for employees and directors amid financial constraints.

VSee Health, Inc. will hold its Annual Meeting on December 15, 2025, to vote on director elections, auditor ratification, and a new equity incentive plan, amidst disclosures of financial difficulties and deferred executive salaries.

Minerva Neurosciences will hold its 2025 Annual Meeting to vote on increasing authorized shares, approving Series A Preferred Stock conversion, and amending its equity incentive plan, crucial for future funding and talent retention.

Allurion Technologies, Inc. is seeking stockholder approval for a reverse stock split, an amended equity incentive plan, option repricing, and the issuance of shares for debt conversion to address NYSE listing requirements and enhance long-term value.

Digital Ally, Inc. is seeking stockholder approval for significant dilutive equity issuances and an increase in its stock option plan to fund operations amidst ongoing net losses.

Tamboran Resources Corporation calls a Special Meeting to ratify a public offering and approve a private placement, totaling approximately $88 million in new equity to fund its development plan.

IBEX Limited has established a formal Nominating Committee to address shareholder concerns and enhance its corporate governance structure.

Neuphoria Therapeutics Inc. issues its definitive proxy statement for its December 12, 2025 Annual Meeting, facing a proxy contest from activist investor LYNX1 Master Fund LP and addressing key governance proposals following a significant clinical trial failure.

CompoSecure, Inc. seeks stockholder approval for a strategic combination with Husky Technologies Limited, valued at approximately $3.953 billion in cash and 55.3 million shares of CompoSecure common stock.

Bowen Acquisition Corp. seeks shareholder approval to extend its business combination deadline to June 14, 2026, to finalize its merger with Shenzhen Qianzhi BioTechnology Co. Ltd.

Lynx1 Master Fund LP, Neuphoria's largest shareholder, is soliciting proxies to elect two independent directors to the Board following the company's failed Phase 3 trial and subsequent dilutive share issuance.

Exact Sciences announced an agreement to be acquired by Abbott, a move expected to close in Q2 2026, aiming to expand patient reach and accelerate cancer diagnostics.

SUNation Energy, Inc. calls its 2025 Annual Meeting to vote on director election, auditor ratification, and a significant amendment to its equity incentive plan, including an evergreen provision, against a backdrop of substantial financial losses and a 'going concern' warning.

Palo Alto Networks, Inc. announced additional equity awards totaling over 2.7 million shares and provided an update on its equity compensation plans.

Plug Power Inc. will hold a Special Meeting on January 15, 2026, to seek stockholder approval for increasing its authorized common stock and amending its charter.

Enviri Corporation announced a definitive agreement to sell its Clean Earth division to Veolia Environnement S.A. and appointed Russell Hochman as President and COO, effective immediately.

Enviri Corporation announced a definitive agreement to sell its Clean Earth division to Veolia Environnement S.A., pending regulatory approval.

iSpecimen Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new 2025 Stock Incentive Plan.

Enviri Corporation published a LinkedIn post on November 21, 2025, regarding the proposed sale of its Clean Earth business to Veolia Environnement S.A.

The ODP Corporation filed supplemental disclosures to its definitive proxy statement in response to shareholder lawsuits alleging misleading information regarding its proposed merger with ACR Ocean Resources LLC.